A hormone detected in a simple blood test can identify patients with sickle cell disease who have developed a life-threatening complication called pulmonary hypertension, according to new research by scientists with NIH's National Heart, Lung, and Blood Institute (NHLBI).
Media Coverage
|
NIH Research Matters